TruSpine Technologies PLC Deutsche Boerse AG

Equities

9Q7

GB00BMZCKL55

Delayed Deutsche Boerse AG Other stock markets 02:04:38 2021-07-06 EDT			5-day change	1st Jan Change
0.0617 ^EUR	-24.29%		-.--%	-.--%

05-07	TruSpine Technologies says CEO Laurence Strauss resigns	AN
03-21	TruSpine Chair Miller buys GBP375,000 in shares	AN

TruSpine submits info to US FDA over Cervic-LOK applictaion

February 19, 2024 at 07:44 am

TruSpine Technologies PLC - London Gatwick Airport-based medical device company - Confirms it has submitted additional documentation to the US Food & Drug Administration regarding its FDA 510(K) application for its screw free spinal stabilisation system product Cervi-LOK. In January, the FDA asked for additional clarifications on certain matters. On Monday, TruSpine says: "In the weeks leading up to the FDA submission, the company has been in dialogue with FDA representatives in order to ensure all clarifications were discussed and answered to the extent possible. A further announcement will be made in due course."

Current stock price: 0.85 pence

12-month change: down 54%

By Greg Rosenvinge, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Latest news about TruSpine Technologies PLC

TruSpine Technologies says CEO Laurence Strauss resigns	05-07	AN
TruSpine Chair Miller buys GBP375,000 in shares	03-21	AN
EARNINGS AND TRADING: Cykel and Mustang push back takeover deadline	03-15	AN
TruSpine Technologies raises GBP290,000 through share issue	03-14	AN
Plant Health eyes Mexico Saori launch; NARF wins deal	02-23	AN
TruSpine submits info to US FDA over Cervic-LOK applictaion	02-19	AN
TruSpine Technologies enters GBP50,000 loan note agreement	02-14	AN
TruSpine secures loan to pay fine; FDA needs Cervi-LOK clarification	01-05	AN
Loss-making TruSpine expects to raise equity or debt soon	12-28	AN
EARNINGS AND TRADING: Celebrus swings to profit; Aquila revenue flat	11-27	AN
Digital 9 dismisses call for strategic review	23-10-30	AN
TruSpine submits further documentation to FDA for Cervi-LOK	23-10-12	AN
TruSpine notes US FDA requires more info on 510k application	23-10-03	AN
EARNINGS: Eden Research loss widens on GBP5 million impairment	23-09-29	AN
TruSpine accepts Aquis findings after investigation	23-09-18	AN
TruSpine Technologies plans to appeal GBP215,000 Aquis fine	23-08-17	AN
TruSpine Technologies raises GBP50,000 through subscription	23-08-15	AN
Truspine finally files US FDA 510k submission for Cervi-LOK	23-07-25	AN
Vertu Motors "optimistic"; Atrato in Ovo Energy deal	23-06-29	AN
TruSpine Technologies takes out GBP100,000 loan from non-exec director	23-04-26	AN
TruSpine terminates services agreement, names new CEO	23-04-05	AN
Downing Renewables acquires two hydropower plants	23-03-02	AN
TruSpine Technologies inks GBP200,000 loan; CEO Ian Roberts steps down	23-02-28	AN
TruSpine says bridge loan funding yet to be received, expects to soon	23-02-20	AN
Diversified plans fundraise; Highcroft ends sale	23-02-08	AN

Chart TruSpine Technologies PLC

Duration

Period

More charts

Company Profile

Sector

More about the company